These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29348829)

  • 1. Roflumilast restores cAMP/PKA/CREB signaling axis for FtMt-mediated tumor inhibition of ovarian cancer.
    Gong S; Chen Y; Meng F; Zhang Y; Wu H; Wu F
    Oncotarget; 2017 Dec; 8(68):112341-112353. PubMed ID: 29348829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis.
    Gong S; Chen Y; Meng F; Zhang Y; Li C; Zhang G; Huan W; Wu F
    Cell Prolif; 2018 Oct; 51(5):e12474. PubMed ID: 30069985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p-CREB and p-DARPP-32 orchestrating the modulatory role of cAMP/PKA signaling pathway enhanced by Roflumilast in rotenone-induced Parkinson's disease in rats.
    Essam RM; Kandil EA
    Chem Biol Interact; 2023 Feb; 372():110366. PubMed ID: 36706892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner.
    Lehrke M; Kahles F; Makowska A; Tilstam PV; Diebold S; Marx J; Stöhr R; Hess K; Endorf EB; Bruemmer D; Marx N; Findeisen HM
    J Mol Cell Cardiol; 2015 Apr; 81():23-33. PubMed ID: 25640159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK.
    Bidwell P; Joh K; Leaver HA; Rizzo MT
    Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):18-29. PubMed ID: 20015475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roflumilast Ameliorates Isoflurane-Induced Inflammation in Astrocytes
    Zhang C; Xing Z; Tan M; Wu Y; Zeng W
    ACS Omega; 2021 Feb; 6(6):4167-4174. PubMed ID: 33644540
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
    Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells.
    Delghandi MP; Johannessen M; Moens U
    Cell Signal; 2005 Nov; 17(11):1343-51. PubMed ID: 16125054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTH receptor: ectopic expression, activity and signaling.
    Forti FL; Dias MH; Armelin HA
    Mol Cell Biochem; 2006 Dec; 293(1-2):147-60. PubMed ID: 16845490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP-Induced Histones H3 Dephosphorylation Is Independent of PKA and MAP Kinase Activations and Correlates With mTOR Inactivation.
    Rodriguez P; Rojas J
    J Cell Biochem; 2016 Mar; 117(3):741-50. PubMed ID: 26335579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury.
    Schreiber R; Hollands R; Blokland A
    Curr Neuropharmacol; 2020; 18(3):188-201. PubMed ID: 31660837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
    Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
    Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
    Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
    Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
    Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism.
    Möllmann J; Kahles F; Lebherz C; Kappel B; Baeck C; Tacke F; Werner C; Federici M; Marx N; Lehrke M
    Diabetes Obes Metab; 2017 Apr; 19(4):496-508. PubMed ID: 27917591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical loading stimulates chondrogenesis via the PKA/CREB-Sox9 and PP2A pathways in chicken micromass cultures.
    Juhász T; Matta C; Somogyi C; Katona É; Takács R; Soha RF; Szabó IA; Cserháti C; Sződy R; Karácsonyi Z; Bakó E; Gergely P; Zákány R
    Cell Signal; 2014 Mar; 26(3):468-82. PubMed ID: 24333667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer.
    Kamrava M; Simpkins F; Alejandro E; Michener C; Meltzer E; Kohn EC
    Oncogene; 2005 Oct; 24(47):7084-93. PubMed ID: 16044162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roflumilast partially reverses smoke-induced mucociliary dysfunction.
    Schmid A; Baumlin N; Ivonnet P; Dennis JS; Campos M; Krick S; Salathe M
    Respir Res; 2015 Oct; 16():135. PubMed ID: 26521141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by CREB-mediated p21 induction: An insight from a plant polyphenol.
    Sun L; Zhao R; Zhang L; Zhang W; He G; Yang S; Song J; Du G
    Biochem Pharmacol; 2016 Mar; 103():40-52. PubMed ID: 26807478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system.
    Jabaris SS; Sumathy H; Girish R; Narayanan S; Sugumar M; Saravana Babu C; Thanikachalam S; Thanikachalam M
    Brain Res; 2015 Oct; 1622():279-91. PubMed ID: 26168894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.